4.72
price down icon1.46%   -0.07
after-market アフターアワーズ: 4.81 0.09 +1.91%
loading
前日終値:
$4.79
開ける:
$4.91
24時間の取引高:
663.38K
Relative Volume:
1.16
時価総額:
$156.69M
収益:
-
当期純損益:
$-86.60M
株価収益率:
-1.6664
EPS:
-2.8324
ネットキャッシュフロー:
$-67.37M
1週間 パフォーマンス:
+4.19%
1か月 パフォーマンス:
+14.56%
6か月 パフォーマンス:
+4.89%
1年 パフォーマンス:
-60.99%
1日の値動き範囲:
Value
$4.3273
$4.945
1週間の範囲:
Value
$4.3273
$4.99
52週間の値動き範囲:
Value
$1.45
$12.76

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
名前
Lexeo Therapeutics Inc
Name
セクター
Healthcare (1157)
Name
電話
(212) 547-9879
Name
住所
345 PARK AVENUE SOUTH, NEW YORK
Name
職員
75
Name
Twitter
Name
次回の収益日
2025-03-24
Name
最新のSEC提出書
Name
LXEO's Discussions on Twitter

LXEO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
4.72 258.57M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-31 開始されました Oppenheimer Outperform
2024-06-13 開始されました Robert W. Baird Outperform
2024-06-06 開始されました H.C. Wainwright Buy
2023-11-28 開始されました Chardan Capital Markets Buy
2023-11-28 開始されました JP Morgan Overweight
2023-11-28 開始されました Leerink Partners Outperform
2023-11-28 開始されました RBC Capital Mkts Outperform
2023-11-28 開始されました Stifel Buy
すべてを表示

Lexeo Therapeutics Inc (LXEO) 最新ニュース

pulisher
06:37 AM

Lexeo Therapeutics price target lowered to $15 from $20 at Chardan - TipRanks

06:37 AM
pulisher
04:16 AM

Chart Analysts Warn of Resistance Near Lexeo Therapeutics Inc. PriceEntry Point & Free Accurate Trade Setup Notifications - sundaytimes.kr

04:16 AM
pulisher
08:03 AM

Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Strategic Positioning in Cardiac Treatments - TipRanks

08:03 AM
pulisher
07:56 AM

Lexeo Therapeutics stock price target lowered to $9 at H.C. Wainwright - Investing.com

07:56 AM
pulisher
12:40 PM

Lexeo Therapeutics Reports Q2 2025 Financial Results - TipRanks

12:40 PM
pulisher
Aug 14, 2025

Lexeo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Reports Q2 Loss as Costs Jump 129% - sharewise.com

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Therapeutics: Can a Deep Pipeline and Regulatory Momentum Offset Earnings Woes? - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Therapeutics Appoints New Chief Financial Officer - TipRanks

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Therapeutics appoints Louis Tamayo as CFO - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights - Yahoo Finance

Aug 14, 2025
pulisher
Aug 12, 2025

What makes Lexeo Therapeutics Inc. stock price move sharplyLow Float Short Squeeze Picks - thegnnews.com

Aug 12, 2025
pulisher
Aug 11, 2025

Lexeo Therapeutics Inc. Matches Institutional Buying FilterBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru

Aug 11, 2025
pulisher
Aug 10, 2025

Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN

Aug 10, 2025
pulisher
Aug 09, 2025

Lexeo Therapeutics Inc. Stock Approaches Key Moving AverageChart Breakout Buy Signal Detection Confirmed - beatles.ru

Aug 09, 2025
pulisher
Aug 04, 2025

Traders Watching For Reversal Pattern in Lexeo Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Oppenheimer Begins Coverage on Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat

Aug 04, 2025
pulisher
Aug 03, 2025

How does Lexeo Therapeutics Inc. generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Lexeo Therapeutics Inc. company’s balance sheetGet real-time updates on market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Lexeo Therapeutics Inc. company’s growth strategyFree Risk Assessment Services - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Lexeo Therapeutics Inc. stockAchieve consistent profits with expert advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Lexeo Therapeutics Inc. as a “Buy”Superior returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-04 05:32:29 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Lexeo Therapeutics Inc.Consistent double returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Lexeo Therapeutics Inc. company’s key revenue driversPhenomenal returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Lexeo Therapeutics Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Lexeo Therapeutics Inc. stockMaximize gains with professional stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Lexeo Therapeutics Inc. a good long term investmentMarket-beating performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Lexeo Therapeutics Inc. in the next 12 monthsBuild a portfolio with strong long-term growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Published on: 2025-08-03 06:15:28 - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What is the dividend policy of Lexeo Therapeutics Inc. stockDynamic profit opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is Lexeo Therapeutics Inc. stock compared to the marketDiscover market opportunities with real-time data - Jammu Links News

Aug 02, 2025
pulisher
Jul 31, 2025

Lexeo Therapeutics Analyst Begins Coverage on Bullish Note; Top 3 Initiations for Thursday - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga

Jul 31, 2025
pulisher
Jul 31, 2025

Oppenheimer Initiates Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $20 - 富途牛牛

Jul 31, 2025
pulisher
Jul 31, 2025

Lexeo Therapeutics Initiates Coverage: Oppenheimer Outperform Rating with $20 PT - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Lexeo Therapeutics shares rise 7.31% premarket after FDA grants breakthrough therapy designation to LX2006. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating By Investing.com - Investing.com India

Jul 31, 2025
pulisher
Jul 31, 2025

Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating - Investing.com Australia

Jul 31, 2025
pulisher
Jul 31, 2025

Should I hold or sell Lexeo Therapeutics Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Stifel Reiterates Buy Rating for Lexeo Therapeutics with $21 Price Target Following FDA Breakthrough Therapy Designation for LX2006 - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Candlestick Reversal Detected on Lexeo Therapeutics Inc.’s ChartPotential Breakout Stock List Published This Week - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Lexeo Therapeutics' LX2006 Receives Breakthrough Therapy Designation from FDA, Shares Rise 17% - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Lexeo Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowGrowth Based Stock Signal Screener Updated - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

11 Best New Penny Stocks to Buy Right Now - Insider Monkey

Jul 30, 2025
pulisher
Jul 29, 2025

What does LXEO's flat EPS in 2024 suggest for investors? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

How did LXEO's operating expenses trend in Q4 2024? - AInvest

Jul 29, 2025

Lexeo Therapeutics Inc (LXEO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
大文字化:     |  ボリューム (24 時間):